Data / Drug companies / Shield Pharmaceuticals Corp
Shield Pharmaceuticals Corp: 78 products in the FDA NDC directory, labeler code 83059
Shield Pharmaceuticals Corp (labeler code 83059) lists 78 products in the FDA National Drug Code Directory, covering 19 finished drugs by generic name. By type: 52 over the counter drugs, 26 drugs for further processing. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 6, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 83059
- Products in commercial distribution
- 78
- Packages
- 66
- Finished drugs by generic name
- 19
- Prescription products
- 0
- Over the counter products
- 52
- Flagged as original packager
- 45 of 45 products that carry the flag
- Started marketing in the last 12 months
- 49
- Earliest marketing start
- December 6, 2023
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 44 | 56.4% |
| Drugs for further processing | 26 | 33.3% |
| Generic drugs (ANDA) | 8 | 10.3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 52 | 66.7% |
| Drugs for further processing | 26 | 33.3% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Acetaminophen, dextromethorphan hbr, phenylephrine hcl | 5 | 45 |
| Ibuprofen | 5 | 190 |
| Diphenhydramine hydrochloride | 5 | 127 |
| Acetaminophen | 4 | 214 |
| Acetaminophen, guaifenesin, phenylephrine | 4 | 1 |
| Simethicone | 3 | 86 |
| Famotidine | 3 | 138 |
| Diphenhydramine hcl 25 mg | 3 | 6 |
| Bismuth subsalicylate 262 mg | 2 | 4 |
| Dextromethorphan hbr | 2 | 22 |
| Acetaminophen, pyrilamine maleate, caffeine | 2 | 1 |
| Docusate sodium 50 mg, sennosides 8.6 mg | 1 | 1 |
| Acetaminophen, guaifenesin | 1 | 6 |
| Caffeine | 1 | 38 |
| Bismuth subsalicylate | 1 | 80 |
| Docusate sodium, sennosides | 1 | 18 |
| Meclizine hcl | 1 | 32 |
| Acetaminophen 500 mg | 1 | 6 |
| Acetaminophen, dextromethorphan hbr, doxylamine succinate | 1 | 40 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule, liquid filled | 43 | 55.1% |
| Tablet, coated | 14 | 17.9% |
| Tablet, film coated | 13 | 16.7% |
| Tablet | 8 | 10.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Sleep Aid | 83059-0187 | Capsule, liquid filled | Over the counter monograph drugs | October 6, 2026 |
| Med365 Dye Free Allergy Relief | 83059-0190 | Capsule, liquid filled | Over the counter monograph drugs | October 5, 2026 |
| Med365 Pain Relief | 83059-0186 | Tablet | Over the counter monograph drugs | October 5, 2026 |
| Heartburn Relief | 83059-0185 | Tablet, film coated | Generic drugs (ANDA) | September 24, 2026 |
| Ibuprofen | 83059-0184 | Tablet, coated | Drugs for further processing | September 21, 2026 |
| Allergy plus Sinus Headache | 83059-0162 | Tablet, film coated | Over the counter monograph drugs | September 11, 2026 |
| Severe Sinus Congestion and Pain | 83059-0183 | Tablet, coated | Over the counter monograph drugs | September 10, 2026 |
| Diphenhydramine hcl 25 mg | 83059-0055 | Capsule, liquid filled | Drugs for further processing | September 8, 2026 |
| Acetaminophen 325 mg, guaifenesin 200 mg, phenylephrine hcl 5 mg | 83059-0182 | Tablet | Drugs for further processing | September 4, 2026 |
| Extra Strength Pain Reliever | 83059-0181 | Tablet | Over the counter monograph drugs | September 2, 2026 |
| Nighttime Cold and Flu Multi Symptom Relief | 83059-0177 | Capsule, liquid filled | Over the counter monograph drugs | September 2, 2026 |
| Ibuprofen | 83059-0180 | Tablet, coated | Generic drugs (ANDA) | September 1, 2026 |
| Daytime Cold and Flu Multi Symptom Relief | 83059-0179 | Capsule, liquid filled | Over the counter monograph drugs | August 31, 2026 |
| Daytime Cold and Flu Maximum Strength | 83059-0178 | Capsule, liquid filled | Over the counter monograph drugs | August 31, 2026 |
| Extra Strength Gas Relief | 83059-0076 | Capsule, liquid filled | Over the counter monograph drugs | August 27, 2026 |
| Nighttime Severe Cold and Flu Maximum Strength mini softgels | 83059-0074 | Capsule, liquid filled | Over the counter monograph drugs | August 26, 2026 |
| Daytime Cold and Flu mini Softgels | 83059-0072 | Capsule, liquid filled | Over the counter monograph drugs | August 26, 2026 |
| Sleep aid | 83059-0075 | Capsule, liquid filled | Over the counter monograph drugs | August 17, 2026 |
| Nighttime Sleep Aid | 83059-0073 | Capsule, liquid filled | Over the counter monograph drugs | August 14, 2026 |
| Daytime Cold and Flu mini Softgels | 83059-0071 | Capsule, liquid filled | Over the counter monograph drugs | August 10, 2026 |
| Adult Long Lasting Cough Relief | 83059-0170 | Capsule, liquid filled | Over the counter monograph drugs | August 7, 2026 |
| Extra Strength Gas Relief | 83059-0169 | Capsule, liquid filled | Over the counter monograph drugs | August 7, 2026 |
| Nexmed multi symptom stomach relief | 83059-0092 | Capsule, liquid filled | Over the counter monograph drugs | August 5, 2026 |
| Extra Strength Pain Reliever mini softgels | 83059-0168 | Capsule, liquid filled | Over the counter monograph drugs | August 4, 2026 |
| ValuRx Dye Free Allergy Relief | 83059-0167 | Capsule, liquid filled | Over the counter monograph drugs | August 4, 2026 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.